Browse our phosphodiesterase 2A, CGMP-Stimulated Proteins (PDE2A)

Human phosphodiesterase 2A, CGMP-Stimulated (PDE2A) interaction partners

1. the well-known interaction between AIP (show AIP Proteins) and 2 different isoforms of phosphodiesterases (PDEs), PDE2A3 and PDE4A5, is of particular interest. While the interaction with over-expressed AIP (show AIP Proteins) does not seem to affect PDE2A3 function, the reported effect on PDE4A5 is, in contrast, reduced enzymatic activity.

2. Lu AF33241 represents a novel PDE2A/PDE10A (show PDE10A Proteins) inhibitor tool which can penetrate the blood brain barrier.

3. curcumin exerts its in vitro anti-angiogenic and in vivo anti-tumour properties through combined PDE2 and PDE4 (show PDE4A Proteins) inhibition

4. PDE2A is involved in growth and invasion of human malignant melanoma PMP cells.

5. This study reports the X-ray crystal structure of PDE2A in complex with a highly selective, nanomolar inhibitor (BAY60-7550) at 1.9 A resolution, and the structure of apo (show C9orf3 Proteins) PDE2 at 2.0 A resolution.

6. PDE2 overexpression in healthy cardiomyocytes reduces the rise in cyclic AMP (show APRT Proteins) levels and L-type calcium current amplitude, and abolishes the inotropic effect following acute beta-adrenergic receptor stimulation.

7. Our results demonstrated that the PDE2A2 variant carrying point mutations is expressed in PMP cells and may affect cell cycle progression by modulating cyclin A (show CCNA2 Proteins) expression.

8. the phosphodiesterase 2A isoform localized to mitochondria regulates respiration

9. Inhibition of PDE2 resulted in higher levels of intracellular cAMP than inhibition of PDE3A (show PDE3A Proteins) suggesting this PDE (show ALDH7A1 Proteins) may be the more important regulator of cAMP in human platelets.

10. TNF-alpha (show TNF Proteins)-mediated up-regulation of PDE2 may destabilize endothelial barrier function in sepsis

Mouse (Murine) phosphodiesterase 2A, CGMP-Stimulated (PDE2A) interaction partners

1. Cardiac hypertrophy is inhibited by a local pool of cAMP regulated by PDE2A.

2. Effect of PDE2 inhibition on stress-induced memory impairment is potentially mediated via modulation of neuroplasticity-related NMDAR (show GRIN1 Proteins)-CaMKII (show CAMK2G Proteins)-cGMP/cAMP signaling.

3. We conclude that increased AM PDE2A is an important negative regulator of macrophage iNOS (show NOS2 Proteins) expression.

4. results demonstrate strong presynaptic inhibition by natriuretic peptides in the brain and suggest important physiological and behavioral roles of PDE2A in modulating neurotransmitter release

5. cGMP binding to PDE2 GAF-B activates the enzyme rapidly, stoichiometrically, and in an all or none fashion, rather than variably over a large range of cyclic nucleotide concentrations

6. HV(T)-induced endothelial barrier dysfunction resulted from a simultaneous increase in NO/sGC (show NPR1 Proteins)-derived cGMP and PDE2A expression causing decreased cAMP.

7. Phosphodiesterase 2 mediates redox-sensitive endothelial cell proliferation and angiogenesis by thrombin (show F2 Proteins) via Rac1 and NADPH oxidase 2 (show CYBB Proteins).